236 related articles for article (PubMed ID: 28708431)
21. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
22. COST EFFECTIVENESS OF USING TERLIPRESSIN TO TREAT HEPATORENAL SYNDROME.
Ferreira LM; Terrabuio DR; Ferreira CM; Mazo DFC; Haddad LBP
Arq Gastroenterol; 2022; 59(2):268-274. PubMed ID: 35830040
[TBL] [Abstract][Full Text] [Related]
23. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Sharma P; Kumar A; Shrama BC; Sarin SK
Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
[TBL] [Abstract][Full Text] [Related]
24. Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?
Sen S; Mookerjee RP; Jalan R
Gastroenterology; 2002 Dec; 123(6):2160-1. PubMed ID: 12454887
[No Abstract] [Full Text] [Related]
25. Meta-analysis: terlipressin therapy for the hepatorenal syndrome.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(6):935-44. PubMed ID: 16948805
[TBL] [Abstract][Full Text] [Related]
26. Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation.
Caraceni P; Santi L; Mirici F; Montanari G; Bevilacqua V; Pinna AD; Bernardi M
Dig Liver Dis; 2011 Mar; 43(3):242-5. PubMed ID: 20833118
[TBL] [Abstract][Full Text] [Related]
27. Terlipressin and albumin combination treatment in hepatorenal syndrome.
Danalioglu A; Cakaloglu Y; Karaca C; Aksoy N; Akyuz F; Ozdil S; Demir K; Besisik F; Boztas G; Mungan Z; Kaymakoglu S; Okten A
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
[TBL] [Abstract][Full Text] [Related]
28. Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.
Muñoz LE; Alcalá EG; Cordero P; Martínez MA; Vázquez NY; Galindo S; Mendoza E; Segura JJ
Ann Hepatol; 2009; 8(3):207-11. PubMed ID: 19841499
[TBL] [Abstract][Full Text] [Related]
29. [Meta-analysis of terlipressin in treatment of hepatorenal syndrome: an update].
Zhang ZF; Yang N; Zhao G; Liu LN; Wang YD; Duan ZJ
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1970-4. PubMed ID: 19950571
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological treatment of hepatorenal syndrome: a note of optimism.
Salerno F; Cazzaniga M; Gobbo G
J Hepatol; 2007 Nov; 47(5):729-31. PubMed ID: 17854944
[No Abstract] [Full Text] [Related]
31. Recent advances in the management of hepato-renal syndrome (HRS).
Fabrizi F; Martin P; Messa P
Acta Clin Belg; 2007; 62 Suppl 2():393-6. PubMed ID: 18284007
[TBL] [Abstract][Full Text] [Related]
32. Poor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature.
Kalil JR; Cerqueira LA; Barbosa DS; Motta MP; Nery Mda S; Bittencourt PL
Arq Gastroenterol; 2009; 46(3):214-8. PubMed ID: 19918689
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in our understanding of hepatorenal syndrome.
Wong F
Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):382-91. PubMed ID: 22614754
[TBL] [Abstract][Full Text] [Related]
34. Terlipressin for hepatorenal syndrome.
Gluud LL; Kjaer MS; Christensen E
Cochrane Database Syst Rev; 2006 Oct; (4):CD005162. PubMed ID: 17054242
[TBL] [Abstract][Full Text] [Related]
35. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
[TBL] [Abstract][Full Text] [Related]
36. [Vasoconstrictors in the treatment of hepatorenal syndrome].
Ortega R; Calahorra B; Ginès P
Nefrologia; 2002; 22 Suppl 5():56-61. PubMed ID: 12107919
[No Abstract] [Full Text] [Related]
37. Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.
Nanda A; Reddy R; Safraz H; Salameh H; Singal AK
J Clin Gastroenterol; 2018 Apr; 52(4):360-367. PubMed ID: 28991106
[TBL] [Abstract][Full Text] [Related]
38. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
Uriz J; Ginès P; Cárdenas A; Sort P; Jiménez W; Salmerón JM; Bataller R; Mas A; Navasa M; Arroyo V; Rodés J
J Hepatol; 2000 Jul; 33(1):43-8. PubMed ID: 10905585
[TBL] [Abstract][Full Text] [Related]
39. [Hepatorenal syndrome: diagnosis, treatment and prevention].
Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
[TBL] [Abstract][Full Text] [Related]
40. Noradrenaline is as Effective as Terlipressin in Hepatorenal Syndrome Type 1: A Prospective, Randomized Trial.
Goyal O; Sidhu SS; Sehgal N; Puri S
J Assoc Physicians India; 2016 Sep; 64(9):30-35. PubMed ID: 27762512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
